These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26813876)

  • 1. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
    Sun L; Liu L; Fu H; Wang Q; Shi Y
    Med Sci Monit; 2016 Jan; 22():289-94. PubMed ID: 26813876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
    Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
    Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
    Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
    Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
    Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
    Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.
    Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
    Zhang D; Ni Z; Xu X; Xiao J
    Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased microRNA-143 expression and its tumor suppressive function in human oral squamous cell carcinoma.
    Ni ZY; Lin FO; Liu DF; Xiao J
    Genet Mol Res; 2015 Jun; 14(2):6943-52. PubMed ID: 26125902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinoma.
    Liao L; Wang J; Ouyang S; Zhang P; Wang J; Zhang M
    Med Sci Monit; 2015 Mar; 21():776-81. PubMed ID: 25791131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in miRNA expression patterns in whole blood of OSCC patients.
    Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
    In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-187* is a potential biomarker for oral carcinoma.
    Liu CJ; Lin JS; Cheng HW; Hsu YH; Cheng CY; Lin SC
    Clin Oral Investig; 2017 May; 21(4):1131-1138. PubMed ID: 27324473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of altered miRNA expression in whole blood of OSCC patients.
    Ries J; Baran C; Wehrhan F; Weber M; Neukam FW; Krautheim-Zenk A; Nkenke E
    Oncol Rep; 2017 Jun; 37(6):3467-3474. PubMed ID: 28498442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
    Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
    Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Significance of Periostin in Tissues and Serum in Oral Leukoplakia and Squamous Cell Carcinoma.
    Guan WQ; Li Q; Ouyang QM
    Cancer Biother Radiopharm; 2019 Sep; 34(7):444-450. PubMed ID: 31170012
    [No Abstract]   [Full Text] [Related]  

  • 18. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
    Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D
    Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.